Literature DB >> 2670167

Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs.

V P Gannon1, C L Gyles, B P Wilcock.   

Abstract

Escherichia coli K12 strains TB1(pCG5), with the genes for Shiga-like toxin IIv from an edema disease isolate of E. coli and TB1(pCG5-1), with the toxin genes inactivated by transposon mutagenesis, were used to test the hypothesis that Shiga-like toxin IIv was the same as edema disease principle. Ammonium sulfate precipitated culture supernatants from the pair of E. coli K12 strains and from a wild edema disease isolate of E. coli (E145) were tested for their ability to induce signs and lesions of edema disease in intravenously inoculated weaned pigs. Similar preparations from E. coli which produce Shiga-like toxins I and II were also tested. Preparations from E. coli TB1 (pCG5) and E145 contained high levels of Shiga-like toxin IIv and induced signs and lesions similar to those seen in edema disease, whereas preparations from E. coli TB1 (pCG5-1) failed to induce signs or lesions of edema disease. All Shiga-like toxin preparations produced delayed neurological signs, fibrinoid necrosis of arterioles and hemorrhages in the cerebellum of pigs. High doses of Shiga-like toxin IIv were associated with superficial necrosis of the colonic epithelium and vasculitis. Shiga-like toxins I and II resulted in kidney lesions but no enteric pathology. Shiga-like toxin II preparations had the lowest median lethal dose for pigs, Shiga-like toxin IIv was intermediate and Shiga-like toxin I was the least toxic.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670167      PMCID: PMC1255716     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  26 in total

1.  Experimental edema disease (hemolytic Escherichia coli toxemia) in pigs and in mice.

Authors:  D W GREGORY
Journal:  Am J Vet Res       Date:  1960-01       Impact factor: 1.156

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Pathologic changes in edema disease of swine.

Authors:  H J Kurtz; M E Bergeland; D M Barnes
Journal:  Am J Vet Res       Date:  1969-05       Impact factor: 1.156

4.  Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada.

Authors:  W M Johnson; H Lior; G S Bezanson
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

5.  The hemolytic-uremic syndrome is a syndrome.

Authors:  B S Kaplan; K N Drummond
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

6.  Taxonomy and epidemiology of gram-negative bacterial plasmids studied by DNA-DNA filter hybridization in formamide.

Authors:  A F Roussel; Y A Chabbert
Journal:  J Gen Microbiol       Date:  1978-02

7.  Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes.

Authors:  F Koster; J Levin; L Walker; K S Tung; R H Gilman; M M Rahaman; M A Majid; S Islam; R C Williams
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

8.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Experimental edema disease of swine (E. coli enterotoxemia). 3. Pathology and pathogenesis.

Authors:  R E Clugston; N O Nielsen; D L Smith
Journal:  Can J Comp Med       Date:  1974-01

10.  Experimental edema disease of swine (E. coli enterotoxemia). I. Dectection and preparation of an active principle.

Authors:  R E Clugston; N O Nielsen
Journal:  Can J Comp Med       Date:  1974-01
View more
  13 in total

1.  Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.

Authors:  K Ramotar; B Boyd; G Tyrrell; J Gariepy; C Lingwood; J Brunton
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Purification and characterization of an Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 4.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

5.  Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.

Authors:  Kwang-Il Jeong; Saul Tzipori; Abhineet S Sheoran
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 6.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Production and characterization of protective human antibodies against Shiga toxin 1.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation.

Authors:  Rebecca Crepeau; Abraham Matar; Thomas R Spitzer; Simon Robson; Vimukthi Pathiraja; David H Sachs; Christene A Huang; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

9.  Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit.

Authors:  G J Tyrrell; K Ramotar; B Toye; B Boyd; C A Lingwood; J L Brunton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

10.  Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine.

Authors:  B T Bosworth; J E Samuel; H W Moon; A D O'Brien; V M Gordon; S C Whipp
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.